Compare CYTK & STWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | STWD |
|---|---|---|
| Founded | 1997 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 7.4B |
| IPO Year | 2004 | 2009 |
| Metric | CYTK | STWD |
|---|---|---|
| Price | $60.52 | $17.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 4 |
| Target Price | ★ $87.56 | $20.13 |
| AVG Volume (30 Days) | 1.7M | ★ 3.0M |
| Earning Date | 05-25-2026 | 05-26-2026 |
| Dividend Yield | N/A | ★ 10.95% |
| EPS Growth | N/A | ★ 4.55 |
| EPS | N/A | ★ 1.15 |
| Revenue | $13,368,000.00 | ★ $1,844,289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $302.66 | $17.66 |
| P/E Ratio | ★ N/A | $15.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.31 | $16.59 |
| 52 Week High | $70.98 | $20.99 |
| Indicator | CYTK | STWD |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 38.26 |
| Support Level | $59.25 | N/A |
| Resistance Level | $65.93 | $18.56 |
| Average True Range (ATR) | 2.76 | 0.33 |
| MACD | -0.35 | -0.03 |
| Stochastic Oscillator | 18.21 | 15.97 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment, and Investing & Servicing Segment. The company generates the majority of its revenue from the Commercial and Residential Lending Segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.